APELLIS PHARMACEUTICALS INC. - COMMON STOCK
33.46
03-1月-25 16:45:00
15 分の遅延
株式
+0.30
+0.90%
本日の幅
33.16 - 34.15
ISIN
N/A
ソース
NASDAQ
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
01 9 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
24 8 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports Second Quarter 2022 Financial Results
08 8 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 8 2022 16:05:02 提供 Nasdaq GlobeNewswire
-
01 8 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
27 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
19 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
14 7 2022 10:01:15 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 7 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
22 6 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
10 6 2022 03:00:00 提供 Nasdaq GlobeNewswire
-
07 6 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 6 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
01 6 2022 16:05:00 提供 Nasdaq GlobeNewswire
-
01 6 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
12 5 2022 11:05:00 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 5 2022 16:23:03 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals to Present at the Bank of America Securities 2022 Healthcare Conference
05 5 2022 16:05:04 提供 Nasdaq GlobeNewswire
-
Apellis Pharmaceuticals Reports First Quarter 2022 Financial Results
04 5 2022 16:05:03 提供 Nasdaq GlobeNewswire
-
Apellis Announces Dr. Peter Hillmen, Renowned Hematologist and PNH Expert, to Join Company
03 5 2022 07:00:01 提供 Nasdaq GlobeNewswire